AEGON N.V. - Summary of Annual General Meeting of Shareholders

THE HAGUE, Netherlands, April 29, 2010 -

    - All Resolutions of the Annual General Meeting of Shareholders Adopted
    - Mr. Rob Routs Succeeds Mr. Dudley Eustace as Chairman of the
      Supervisory Board
    - No Dividend for 2009

Resolutions of the 2010 Annual General Meeting of Shareholders*

The decisions made by the shareholders at the 2010 Annual General Meeting
of Shareholders (AGM) include the following:

Annual accounts

The AGM adopted the annual accounts for the financial year 2009 and the
members of the Executive Board and Supervisory Board were released from
liability for their duties.

Authorizations Executive Board

The AGM has authorized the Executive Board to issue common shares, to
restrict/exclude pre-emptive rights upon issuing common shares, to issue
common shares under incentive plans and to acquire shares in the company.

Appointment independent auditor

Ernst & Young was appointed as the independent auditor for the Annual
Accounts 2010.

Articles of Association

The AGM adopted the amendments to the Articles of Association of AEGON
N.V.

New Executive Board Remuneration Policy adopted

A new Remuneration Policy for the members of the Executive Board was
adopted. The policy will take effect from January 1, 2010.

Amendment to Supervisory Board Remuneration Policy adopted

The proposal to amend the Remuneration Policy for the members of the
Supervisory Board was adopted.

Reappointment

Mr. K.J. Storm was reappointed as a member of the Supervisory Board for a
term of four years as of April 29, 2010.

Mr. Rob Routs succeeds Mr. Dudley Eustace Chairman of the Supervisory
Board

As previously announced, Mr. Dudley Eustace has stepped down as a member
of the Supervisory Board. Mr. Rob Routs succeeds him as Chairman of the
Supervisory Board.

Dividend 2009

Given the uncertain market environment, AEGON believes that it continues
to be prudent to maintain a substantial capital buffer, as reflected in the
strong capital position. Though impairments on the investment portfolio
improved during the second half of 2009, they remained at elevated levels,
which led to lower cash flows from AEGON's operating units. Consequently,
AEGON decided not to make a dividend payment on its common shares. AEGON's
dividend policy has not changed. It remains AEGON's policy to pay adequate
and growing dividends to the holders of common shares, depending on the
company's cash flow and capital position.

* The full details of the resolutions approved during the shareholders'
meeting may be found in the agenda section of the 2010 AGM at AEGON's
corporate website: www.aegon.com/en/Home/Investors/Publications/AGM/

About AEGON

As an international life insurance, pension and investment company based
in The Hague, AEGON has businesses in over twenty markets in the Americas,
Europe and Asia. AEGON companies employ approximately 28,000 people and have
more than 40 million customers across the globe.

Forward-looking statements

The statements contained in this press release that are not historical
facts are forward-looking statements as defined in the US Private Securities
Litigation Reform Act of 1995. The following are words that identify such
forward-looking statements: aim, believe, estimate, target, intend, may,
expect, anticipate, predict, project, counting on, plan, continue, want,
forecast, goal, should, would, is confident, will, and similar expressions as
they relate to our company. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that are
difficult to predict. We undertake no obligation to publicly update or revise
any forward-looking statements. Readers are cautioned not to place undue
reliance on these forward-looking statements, which merely reflect company
expectations at the time of writing. Actual results may differ materially
from expectations conveyed in forward-looking statements due to changes
caused by various risks and uncertainties. Such risks and uncertainties
include but are not limited to the following:

    - Changes in general economic conditions, particularly in the United
      States, the Netherlands and the United Kingdom;
    - Changes in the performance of financial markets, including emerging
      markets, such as with regard to:
      - The frequency and severity of defaults by issuers in our fixed income
        investment portfolios; and
      - The effects of corporate bankruptcies and/or accounting restatements
        on the financial markets and the resulting decline in the value of
        equity and debt securities we hold;
    - The frequency and severity of insured loss events;
    - Changes affecting mortality, morbidity and other factors that may
      impact the profitability of our insurance products;
    - Changes affecting interest rate levels and continuing low or rapidly
      changing interest rate levels;
    - Changes affecting currency exchange rates, in particular the EUR/USD
      and EUR/GBP exchange rates;
    - Increasing levels of competition in the United States, the Netherlands,
      the United Kingdom and emerging markets;
    - Changes in laws and regulations, particularly those affecting our
      operations, the products we sell, and the attractiveness of certain
      products to our consumers;
    - Regulatory changes relating to the insurance industry in the
      jurisdictions in which we operate;
    - Acts of God, acts of terrorism, acts of war and pandemics;
    - Effects of deliberations of the European Commission regarding the aid
      we received from the Dutch State in December 2008;
    - Changes in the policies of central banks and/or governments;
    - Lowering of one or more of our debt ratings issued by recognized rating
      organizations and the adverse impact such action may have on our
      ability to raise capital and on our liquidity and financial condition;
    - Lowering of one or more of insurer financial strength ratings of our
      insurance subsidiaries and the adverse impact such action may have on
      the premium writings, policy retention, profitability of its insurance
      subsidiaries and liquidity;
    - The effect of the European Union's Solvency II requirements and other
      regulations in other jurisdictions affecting the capital we are
      required to maintain;
    - Litigation or regulatory action that could require us to pay
      significant damages or change the way we do business;
    - Customer responsiveness to both new products and distribution channels;
    - Competitive, legal, regulatory, or tax changes that affect the
      distribution cost of or demand for our products;
    - The impact of acquisitions and divestitures, restructurings, product
      withdrawals and other unusual items, including our ability to integrate
      acquisitions and to obtain the anticipated results and synergies from
      acquisitions;
    - Our failure to achieve anticipated levels of earnings or operational
      efficiencies as well as other cost saving initiatives; and
    - The impact our adoption of the International Financial Reporting
      Standards may have on our reported financial results and financial
      condition.

Further details of potential risks and uncertainties affecting the
company are described in the company's filings with Euronext Amsterdam and
the US Securities and Exchange Commission, including the Annual Report on
Form 20-F. These forward-looking statements speak only as of the date of this
document. Except as required by any applicable law or regulation, the company
expressly disclaims any obligation or undertaking to release publicly any
updates or revisions to any forward-looking statements contained herein to
reflect any change in the company's expectations with regard thereto or any
change in events, conditions or circumstances on which any such statement is
based.

                                                     Full year    Full year
    Key figures - EUR                                     2009         2008
    Underlying earnings before tax                 1.2 billion  1.2 billion
    New life sales                                 2.1 billion  2.6 billion
    Gross deposits (excl. run-off)                  28 billion   35 billion
    Revenue generating investments
    (end of period)                                361 billion  332 billion

    Contact information

    Media relations: Greg Tucker

    +31(0)70-344-8956
    gcc-ir@aegon.com

    Investor relations: Gerbrand Nijman

    +31(0)70-344-8305
    +1-877-548-9668 - toll free USA only
    ir@aegon.com

    www.aegon.com

Contact information: Media relations: Greg Tucker, +31(0)70-344-8956, gcc-ir at aegon.com; Investor relations: Gerbrand Nijman, +31(0)70-344-8305, +1-877-548-9668 - toll free USA only, ir at aegon.com